By combining synthetic biology, computational design, and novel RNA formats, these therapies adapt in real time to disease signals, enabling previously impossible treatments.
Immunotherapy was a game-changer for the cancer field, but immunotherapies using cytokines like IL-2 often cause severe side effects. Researchers are developing a newly engineered blueprint to improve the therapeutic efficacy and safety of IL-2 and other cytokines.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.